Blood-brain barrier: transport studies in isolated brain capillaries and in cultured brain endothelial cells
- PMID: 1958501
- DOI: 10.1016/s1054-3589(08)60034-4
Blood-brain barrier: transport studies in isolated brain capillaries and in cultured brain endothelial cells
Abstract
The development of in vitro BBB models consisting of isolated brain capillaries and cultured brain microvessel endothelial cells has made possible the study of BBB transport phenomena at the cellular level. Basic characteristics of BBB transport of endogenous and exogenous solutes and their biochemical, pharmacological, ontogenic, and pathological regulation mechanisms have been investigated. This information has led not only to a better understanding of BBB transport but also to the construction of strategies for improving drug delivery to the CNS for diagnosis and therapeutics. To elucidate the complexity of BBB transport, in vivo studies are always necessary at some point; however, in vitro systems can be useful complements to the in vivo systems. The tissue culture systems seem to be especially important in the clarification of cellular, biochemical and molecular features of BBB transport. Appropriate systems should be selected or combined, depending on the purpose of the investigation.
Similar articles
-
Blood-brain barrier biology and methodology.J Neurovirol. 1999 Dec;5(6):556-69. doi: 10.3109/13550289909021285. J Neurovirol. 1999. PMID: 10602397 Review.
-
Culture-induced changes in mRNA expression levels of efflux and SLC-transporters in brain endothelial cells.Fluids Barriers CNS. 2020 Apr 22;17(1):32. doi: 10.1186/s12987-020-00193-5. Fluids Barriers CNS. 2020. PMID: 32321539 Free PMC article.
-
Blood-brain barrier transport of a novel micro 1-specific opioid peptide, H-Tyr-D-Arg-Phe-beta-Ala-OH (TAPA).J Neurochem. 2003 Mar;84(5):1154-61. doi: 10.1046/j.1471-4159.2003.01582.x. J Neurochem. 2003. PMID: 12603838
-
Functional role of adenosine receptor subtypes in the regulation of blood-brain barrier permeability: possible implications for the design of synthetic adenosine derivatives.Eur J Pharm Sci. 2003 May;19(1):13-22. doi: 10.1016/s0928-0987(03)00034-4. Eur J Pharm Sci. 2003. PMID: 12729857
-
Development of the blood-brain barrier.Cell Tissue Res. 2003 Oct;314(1):119-29. doi: 10.1007/s00441-003-0751-z. Epub 2003 Sep 4. Cell Tissue Res. 2003. PMID: 12955493 Review.
Cited by
-
Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system.J Physiol. 2005 Jun 1;565(Pt 2):475-86. doi: 10.1113/jphysiol.2005.084038. Epub 2005 Mar 24. J Physiol. 2005. PMID: 15790664 Free PMC article.
-
Exploring the active site of phenylethanolamine N-methyltransferase with 1,2,3,4-tetrahydrobenz[h]isoquinoline inhibitors.Bioorg Med Chem. 2007 Feb 1;15(3):1298-310. doi: 10.1016/j.bmc.2006.11.010. Epub 2006 Nov 10. Bioorg Med Chem. 2007. PMID: 17126018 Free PMC article.
-
Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides.Pharm Res. 1994 Mar;11(3):412-9. doi: 10.1023/a:1018969222130. Pharm Res. 1994. PMID: 8008709
-
Regulators of vascular permeability: potential sites for intervention in the treatment of macular edema.Doc Ophthalmol. 1999;97(3-4):251-60. doi: 10.1023/a:1002196930726. Doc Ophthalmol. 1999. PMID: 10896338 Review.
-
Biotin uptake and transport across bovine brain microvessel endothelial cell monolayers.Pharm Res. 1993 Feb;10(2):282-8. doi: 10.1023/a:1018903330985. Pharm Res. 1993. PMID: 8456078